Restoration of Wild - type p53 Induces Chemo-sensitization in the Gastric Cancer Cell Line with Mutant p53.
- Author:
Ho Young MAENG
;
Sun Young RHA
;
Byung Soh MIN
;
Yong Bae KIM
;
Hyun Joo KWAK
;
Tae Soo KIM
;
Kyu Hyun PARK
;
Nae Choon YOO
;
Ho Young LIM
;
Jin Hyuk CHOI
;
Joo Hang KIM
;
Jae Kyung ROH
;
Jin Sik MIN
;
Byung Soo KIM
;
Hyun Cheol CHUNG
- Publication Type:Original Article
- Keywords:
Wild-type p53;
Chemo-sensitization;
Etoposide;
Cisplatin;
Gastric cancer
- MeSH:
Agar;
Blotting, Southern;
Carboplatin;
Cell Cycle;
Cell Line*;
Cisplatin;
DNA Fragmentation;
Enzyme-Linked Immunosorbent Assay;
Etoposide;
Genes, p53;
Humans;
Stomach Neoplasms*;
Telomerase;
Vinblastine;
Vincristine
- From:Journal of the Korean Cancer Association
1998;30(3):497-507
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: It has been theorized that p53 may be involved in the sensitivity to chemotherapeutic agents. We evaluated the chemosensitivity of wild p53 after transduction into gastric cancer cell lines with mutant p53. MATERIALS AND METHODS: YCC-3(parent cell line with mutant p53), YCC-3v(parent cell line transduced with vector alone) and YCC-3C3(clone with wild p53) cell lines were used in this study. p53 protein expression was measured by ELISA assay. Tumorigenicity and drug sensitivity were evaluated by soft agar and proliferation assay, respectively. Cell cycle analysis was performed by flowcytometry. Telomerase activity was measured by TRAP assay and terminal restriction fragment(TRF) length was measured after Southern blot analysis. RESULTS: Even though p53 production from the YCC-3C3 cell line was three times higher than those of YCC-3 and YCC-3v cell lines, the cell cycle was the same in these three cell lines. In the YCC-3C3 cell line, drug sensitivity to etoposide and cisplatin was increased when we compared it to those of the YCC-3v cell line(etoposide, 50% versus 83%; cisplatin, 67% versus 83%). However, there was no chemo-sensitization effect with vincristine, vinblastine and carboplatin. After exposure to cisplatin, a G0/G1 check-point effect was found in the YCC-3C3 cell line, but not in the YCC-3v cell line. No differences were found in telomerase activity, TRFs length or DNA fragmentation between the YCC-3v and YCC-3C3 cell lines after cisplatin treatment. CONCLUSION: Wild-type p53 gene transduction in the gastric cancer cell line induced sensitization to the cytotoxicity of etoposide and cisplatin. This suggests the possible application of combined chemo-gene therapy with an EP regimen and wild-type p53 in gastric cancer patients with p53 mutation.
